[go: up one dir, main page]

GB201501800D0 - Treatment of medical conditions - Google Patents

Treatment of medical conditions

Info

Publication number
GB201501800D0
GB201501800D0 GBGB1501800.5A GB201501800A GB201501800D0 GB 201501800 D0 GB201501800 D0 GB 201501800D0 GB 201501800 A GB201501800 A GB 201501800A GB 201501800 D0 GB201501800 D0 GB 201501800D0
Authority
GB
United Kingdom
Prior art keywords
treatment
medical conditions
medical
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1501800.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aimsco Ltd
Original Assignee
Aimsco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aimsco Ltd filed Critical Aimsco Ltd
Priority to GBGB1501800.5A priority Critical patent/GB201501800D0/en
Publication of GB201501800D0 publication Critical patent/GB201501800D0/en
Priority to PCT/GB2016/050249 priority patent/WO2016124922A1/en
Priority to EP16704045.0A priority patent/EP3253404A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1501800.5A 2015-02-03 2015-02-03 Treatment of medical conditions Ceased GB201501800D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1501800.5A GB201501800D0 (en) 2015-02-03 2015-02-03 Treatment of medical conditions
PCT/GB2016/050249 WO2016124922A1 (en) 2015-02-03 2016-02-03 Treatment of medical conditions
EP16704045.0A EP3253404A1 (en) 2015-02-03 2016-02-03 Treatment of medical conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1501800.5A GB201501800D0 (en) 2015-02-03 2015-02-03 Treatment of medical conditions

Publications (1)

Publication Number Publication Date
GB201501800D0 true GB201501800D0 (en) 2015-03-18

Family

ID=52705705

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1501800.5A Ceased GB201501800D0 (en) 2015-02-03 2015-02-03 Treatment of medical conditions

Country Status (3)

Country Link
EP (1) EP3253404A1 (en)
GB (1) GB201501800D0 (en)
WO (1) WO2016124922A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013282995B2 (en) * 2012-06-25 2018-10-04 Aimsco Limited Formulation comprising CRH and alpha - 2 - immunoglobulin
GB201322948D0 (en) * 2013-12-23 2014-02-12 Aimsco Ltd Improved formulation
GB201408171D0 (en) * 2014-05-08 2014-06-25 Aimsco Ltd Formulation and method of manufacture

Also Published As

Publication number Publication date
EP3253404A1 (en) 2017-12-13
WO2016124922A1 (en) 2016-08-11

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
IL259110A (en) Treatment of osteoarthritis
IL252839A0 (en) Treatment of pemphigus
IL253803B (en) Treatment of hypoparathyroidism
PT3212233T (en) Combination therapy for treatment of disease
PL3851537T3 (en) Treatment of hyperbilirubinemia
GB201701673D0 (en) Methods of well treatment
IL285003A (en) Treatment of joint conditions
SG11201609652RA (en) Treatment of polybacterials infections
PT3273955T (en) Treatment of respiratory diseases
IL255770B (en) Therapeutic uses of l-4-chlorokynurenine
ZA201705847B (en) Treatment of pain
GB201416832D0 (en) Methods of treatment
GB201408297D0 (en) Treatment of cancer
SG11201705889VA (en) Prevention or Treatment of Uratic or Gouty Diseases
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
EP3271017A4 (en) Treatment of skin conditions
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201512139D0 (en) Methods of treatment
GB201514729D0 (en) Treatment of haemorrhoids
GB201417456D0 (en) Treatment of cancer
GB201501800D0 (en) Treatment of medical conditions
GB201504413D0 (en) Treatment of disease
GB201621398D0 (en) Treatment of emt-associated disease
GB201522257D0 (en) Treatment of autism

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)